ScieGen Pharmaceuticals, INC.

Form 483 issued January 9, 2015 · Hauppauge, New York

Inspection
Dec 29, 2014 – Jan 9, 2015
Investigator
Robert C. Horan
Observations
1
Pages
1
FEI number
3008298016

In short: On January 9, 2015, FDA issued a Form 483 with 1 observation to ScieGen Pharmaceuticals, INC. in Hauppauge, New York (FEI 3008298016) after an inspection that ran Dec 29, 2014 – Jan 9, 2015. The investigator was Robert C. Horan. Most observations concern quality system; the most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.22(d) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at ScieGen Pharmaceuticals, INC.?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit). The opening words of each observation are shown on this page.

Who inspected ScieGen Pharmaceuticals, INC.?

Robert C. Horan is named on this Form 483, for the inspection of Dec 29, 2014 – Jan 9, 2015. Each investigator has a profile showing what they cite most.

When was ScieGen Pharmaceuticals, INC. inspected by FDA?

The inspection ran Dec 29, 2014 – Jan 9, 2015, and the Form 483 is dated January 9, 2015.

How do I get the full Form 483 for ScieGen Pharmaceuticals, INC.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free